id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-P-2322-0003,FDA,FDA-2020-P-2322,Interim Response to Covington & Burling LLP from FDA CDER,Other,Response(s),2021-06-24T04:00:00Z,2021,6,2021-06-24T04:00:00Z,,2021-06-24T15:58:10Z,,0,0,0900006484bac316